The DOI matches its Crossref record; 469 of the 469 references it cites were found in a registry or an index.
The serotonergic system in ageing and Alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 469
Incidence and subtypes of dementia in southern Taiwan Impact of socio‐demographic factors
Liu, C.-K., Lai, C. L., Tai, C., Lin, R. T., Yen, Y.-C., & Howng, S. L. (1998) · Neurology · doi:10.1212/wnl.50.6.1572 · Cited by 119
Chen, C., Eastwood, S. L., Hope, T., McDonald, B., Francis, P. T., & Esiri, M. M. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00254.x · Cited by 118
Nilsson, O., Brundin, P., & Björklund, A. (1990) · Brain Research · doi:10.1016/0006-8993(90)90596-4 · Cited by 118
Liu, J. P., & Lauder, J. M. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330208 · Cited by 118
The unsolved relationship of brain aging and late-onset Alzheimer disease
Kern, A., & Behl, C. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.016 · Cited by 117
Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients
Lorke, D. E., Lü, G., Cho, E. Y. P., & Yew, D. T. W. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-36 · Cited by 117
Morales, M., Battenberg, E., de Lecea, L., Sanna, P. P., & Bloom, F. E. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)88406-3 · Cited by 117
Christensen, R., Marcussen, A. B., Wörtwein, G., Knudsen, G. M., & Aznar, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.009 · Cited by 117
Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases.
Monaco, F., Fumero, S., Mondino, A., & Mutani, R. (1979) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.42.7.640 · Cited by 117
Lambe, E. K., & Aghajanian, G. K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09955.2001 · Cited by 117
Mowla, A., Mosavinasab, M., Haghshenas, H., & Haghighi, A. B. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31814b98c1 · Cited by 116 · cited 3×
“Treatments with selective serotonin reuptake inhibitors (SSRIs) increase the CSF concentration of 5-HT and improve cognitive function and memory in patients with dementia of AD type (Marksteiner et al., 2003; Mossello et al., 2008; Mowla et al., 2007; Tohgi et al., 1995).”
Moser, P. C., Bergis, O. E., Jegham, S., Lochead, A. W., Duconseille, E., Terranova, J.-P., Caille, D., Berque‐Bestel, I., Lezoualc’h, F., Fischmeister, R., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034249 · Cited by 116
Míguez, J. M., Aldegunde, M., Paz-Valiñas, L., Recio, J., & Sánchez‐Barceló, E. J. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050225 · Cited by 115
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS
Turner, M. R., Rabiner, E. A., Hammers, A., Al‐Chalabi, A., Grasby, P. M., Shaw, C. E., Brooks, D. J., & Leigh, P. N. (2005) · Brain · doi:10.1093/brain/awh428 · Cited by 115
Texture of the Nervous System of Man and the Vertebrates
y Cajal, S. R. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6730-4 · Cited by 114
Loubinoux, I., Pariente, J., Boulanouar, K., Carel, C., MANELFE, C., Rascol, O., Celsis, P., & Chollet, F. (2002) · NeuroImage · doi:10.1006/nimg.2001.0957 · Cited by 114
Experimental studies on the role of serotonin in cognition
Sirviö, J., Riekkinen, P. J., Jäkälä, P., & Riekkinen, P. J. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90060-4 · Cited by 113
Middlemiss, D. N., Palmer, A. M., Edel, N., & Bowen, D. M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13069.x · Cited by 113
Madjid, N., Elvander-Tottie, E., Lüttgen, M., Meister, B., Sandin, J., Kuzmin, A., Stiedl, O., & Ögren, S. O. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092262 · Cited by 113
Acute administration of citalopram facilitates memory consolidation in healthy volunteers
Harmer, C. J., Bhagwagar, Z., Cowen, P. J., & Goodwin, G. M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1151-x · Cited by 112
The effects of aging on spinal neurochemistry in the rat
Ko, M. L., King, M. A., Gordon, T. L., et al. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(96)00216-x · Cited by 112
Age-related decline of serotonin transporters in living human brain of healthy males
Yamamoto, M., Suhara, T., Okubo, Y., Ichimiya, T., Sudo, Y., Inoue, M., Takano, A., Yasuno, F., Yoshikawa, K., & Tanada, S. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01745-9 · Cited by 112
Cell loss in the nucleus raphes dorsalis in alzheimer's disease
Aletrino, M. A., Vogels, O. J. M., van Domburg, P. H. M. F., & ten Donkelaar, H. J. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90073-7 · Cited by 111
Nazarali, A. J., & Reynolds, G. P. (1992) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711237 · Cited by 111
Immunohistochemical and neurochemical correlates of learning deficits in aged rats
Stemmelin, J., Lazarus, C., Cassel, S. L., Kelche, C. R., & Cassel, J. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00561-8 · Cited by 110
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease
Thompson, S., Lanctôt, K. L., & Herrmann, N. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.5.425 · Cited by 109
Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation
Halliday, G. M., McCann, H., Pamphlett, R., Brooks, W. S., Creasey, H. M., McCusker, E. A., Cotton, R. G. H., Broe, G. A., & Harper, C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227741 · Cited by 109
Martín‐Cora, F., & Pazos, Á. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705576 · Cited by 108
Gender-specific aging effects on the serotonin 1A receptor
MELTZER, C. C., Drevets, W. C., Price, J. C., Mathis, C. A., Lopresti, B. J., Greer, P. J., Villemagne, V. L., Holt, D. P., Mason, N. S., Houck, P. R., et al. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03211-x · Cited by 107
Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model
Rodriguez, J. J., Jones, V. C., & Verkhratsky, A. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832be77d · Cited by 106
Self-citationNeuropharmacology of 5‐hydroxytryptamine
Green, A. R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706427 · Cited by 104
PEREZGARCIA, G., & Meneses, A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.05.005 · Cited by 104
The Human Serotonin 5-HT4 Receptor Regulates Secretion of Non-amyloidogenic Precursor Protein
Robert, S. J., Zugaza, J. L., Fischmeister, R., Gardier, A. M., & Lezoualc'h, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109008200 · Cited by 104
VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux
Mohler, E. G., Shacham, S., Noiman, S., Lezoualc’h, F., Robert, S. J., Gastineau, M., Rutkowski, J., Marantz, Y., Dumuis, A., Bockaert, J., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.016 · Cited by 103
Duncan, M. J., Short, J., & Wheeler, D. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01311-6 · Cited by 103
The 5-HTTPR*S/*L Polymorphism and Aggressive Behavior in Alzheimer Disease
Sukonick, D. L., Pollock, B. G., Sweet, R. A., Mulsant, B. H., Rosen, J., Klunk, W. E., Kastango, K. B., DeKosky, S. T., & Ferrell, R. E. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1425 · Cited by 103
Imaging of the 5-HT2A system: age-, gender-, and Alzheimer’s disease-related findings
Versijpt, J., Van Laere, K. J., Dumont, F., Decoo, D., Vandecapelle, M., Santens, P., Goethals, I., Audenaert, K., Slegers, G., Dierckx, R. A., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00137-9 · Cited by 102 · cited 6×
“N,N-dimethyl-5-(1,3,5-trimethylpyrazol-4-yl)-1,2,3,4-tetrahydronaphthalen-2-amine; Ab, amyloid beta; Ab1–42, Fibrillogenic amyloid beta; AbPPswe/PS1DE9, Transgenic mouse expressing APP swedish and PS1DE9 mutations; BDNF, brain derived neurotrophic factor; BF, beaded fibres; Bmax, receptor density; BP, binding potencia…”
InfluentialThe serotonin receptors : from molecular pharmacology to human therapeutics
Roth, B. L. (2006) · Cited by 101
Misane, I., & Ögren, S. O. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300024 · Cited by 101
Rubinsztein, J. S., Rogers, R. D., Riedel, W. J., Mehta, M. A., Robbins, T. W., & Sahakian, B. J. (2001) · Psychopharmacology · doi:10.1007/s002130000655 · Cited by 100
Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat
Lüttgen, M., Elvander-Tottie, E., Madjid, N., & Ögren, S. O. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.007 · Cited by 100
Effect of Age on Human Brain Serotonin (S‐1) Binding Sites
Marcusson, J. O., Oreland, L., & Winblad, B. G. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb06098.x · Cited by 98
Lehmann, O., Jeltsch‐David, H., Lehnardt, O., Pain, L., Lazarus, C., & Cassel, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00881.x · Cited by 97
Effect of 5-HT7 antagonist SB-269970 in the modulation of working and reference memory in the rat
Gasbarri, A., Cifariello, A., Pompili, A., & Meneses, A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.12.020 · Cited by 97
Postmortem serotoninergic correlates of cognitive decline in Alzheimer??s disease
Lai, M. K. P., Tsang, S. W. Y., Francis, P. T., Keene, J., Hope, T., Esiri, M. M., Spence, I., & Chen, C. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00021 · Cited by 96
West, P. J., Marcy, V. R., Marino, M. J., & Schaffhauser, H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.061 · Cited by 95
Vertes, R. P., & Crane, A. M. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970217)378:3<411::aid-cne8>3.0.co;2-6 · Cited by 95
Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases
Cheng, A. V., Ferrier, I. N., Morris, C. M., Jabeen, S., Sahgal, A., McKeith, I. G., Edwardson, J. A., Perry, R. H., & Perry, E. K. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90193-b · Cited by 95
Bucht, G., Adolfsson, R., Gottfries, C. G., Roos, B. E., & Winblad, B. G. (1981) · Journal of Neural Transmission · doi:10.1007/bf01248951 · Cited by 94
Gross‐Isseroff, R., Salama, D., Israeli, M., & Biegon, A. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)90081-l · Cited by 92
VIALLI, M., & Erspamer, V. (1937) · Cell and Tissue Research · doi:10.1007/bf00391792 · Cited by 92
Cognitive Deficit Induced by Acute Tryptophan Depletion in Patients With Alzheimer’s Disease
Porter, R., Lunn, B. S., Walker, L. L. M., Gray, J. M., Ballard, C. G., & O'Brien, J. T. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.638 · Cited by 91
Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease
Ouchi, Y., Yoshikawa, E., Futatsubashi, M., Yagi, S., Ueki, T., & Nakamura, K. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.063008 · Cited by 91
Sambeth, A., Blokland, A., Harmer, C. J., Kilkens, T. O. C., Nathan, P. J., Porter, R., Schmitt, J. A. J., Scholtissen, B., Sobczak, S., Young, A. H., et al. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.11.009 · Cited by 90
Effect of aging in human cortical pre- and postsynaptic serotonin binding sites
Arranz, B., Eriksson, A., Mellerup, E. T., Plenge, P., & Marcusson, J. O. (1993) · Brain Research · doi:10.1016/0006-8993(93)90286-v · Cited by 90
Tohgi, H., Abe, T., Takahashi, S., Kimura, M., Takahashi, J., & Kikuchi, T. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90322-x · Cited by 88
The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
Wilcock, G. K., Esiri, M. M., Bowen, D. M., & Hughes, A. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.842 · Cited by 87
Aging of the serotonergic system in the rat forebrain: An immunocytochemical and neurochemical study
van Luijtelaar, M. G. P. A., Tonnaer, J. A. D. M., & Steinbusch, H. W. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90032-s · Cited by 87
Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET
Marner, L., Gillings, N., Madsen, K., Erritzøe, D., Baaré, W. F. C., Svarer, C., Hasselbalch, S. G., & Knudsen, G. M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.054 · Cited by 87
The serotonin 5-HT4 receptor and the amyloid precursor protein processing
Lezoualc’h, F., & Robert, S. J. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00157-2 · Cited by 86
The effects of serotonin depletion and raphe grafts on hippocampal electrophysiology and behavior
Richter‐Levin, G., & Segal, M. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01585.1991 · Cited by 86
Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats
Marcussen, A. B., Flagstad, P., Kristjansen, P. E. G., Johansen, F. F., & Englund, U. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00910.x · Cited by 86
The 5-HT7 receptor: Role in novel object discrimination and relation to novelty-seeking behavior
Ballaz, S., Akil, H., & Watson, S. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.043 · Cited by 86
SEROTONERGIC MECHANISMS IN AMYOTROPHIC LATERAL SCLEROSIS
Sandyk, R. (2006) · International Journal of Neuroscience · doi:10.1080/00207450600754087 · Cited by 86
Mitchell, E. S., Sexton, T. J., & Neumaier, J. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301284 · Cited by 85
Porter, R., Lunn, B. S., & O'Brien, J. T. (2002) · Psychological Medicine · doi:10.1017/s0033291702006906 · Cited by 85
Neurotransmitter deficits in a non-multi-infarct category of vascular dementia
Wallin, A., Alafuzoff, I. I., Carlsson, A. C., Eckernäs, S. ‐., Gottfries, C. G., Karlsson, I., Svennerholm, L. T., & Winblad, B. G. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03807.x · Cited by 84
Lieben, C. K. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00102-5 · Cited by 83
Borroni, B., Grassi, M., Agosti, C., Costanzi, C., Archetti, S., Franzoni, S., Caltagirone, C., Luca, M. D., Caimi, L., & Padovani, A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.029 · Cited by 82
5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain.
Marcusson, J. O., Alafuzoff, I. I., Bäckström, I. T., Ericson, E., Gottfries, C. G., & Winblad, B. G. (1987) · Brain Research · doi:10.1016/0006-8993(87)90492-6 · Cited by 81
Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders
Kovács, G. G., Klöppel, S., Fischer, I., Dorner, S., Lindeck‐Pozza, E., Birner, P., Bötefür, I. C., Pilz, P. K. D., Volk, B., & Budka, H. (2003) · Neuroreport · doi:10.1097/00001756-200301200-00014 · Cited by 81
Perry, E. K., Perry, R. H., Candy, J. M., FAIRBAIRN, A. F., Blessed, G., Dick, D. J., & Tomlinson, B. E. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90402-6 · Cited by 81
Ueda, S., Sakakibara, S., & Yoshimoto, K. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.065 · Cited by 80
Carli, M., Lazarova, M. I., Tatarczynska, E., & SAMANIN, R. (1992) · Brain Research · doi:10.1016/0006-8993(92)91451-j · Cited by 80
Marcos, B., Chuang, T. T., Gil-Bea, F. J., & Ramírez, M. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.281 · Cited by 79
Carli, M., Tranchina, S., & SAMANIN, R. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90533-a · Cited by 79
Serotonergic regulation of associative learning
Harvey, J. A. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00068-x · Cited by 79
Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment
Truchot, L., Costes, N., Zimmer, L., Laurent, B., Bars, D. L., Thomas-Antérion, C., Croisile, B., Mercier, B., Hermier, M., Vighetto, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000271377.52421.4a · Cited by 79
Serotonin Type 3 Receptor Genes: HTR3A, B, C, D, E
Niesler, B., Kapeller, J., Hammer, C., & Rappold, G. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.501 · Cited by 78
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy
Bowen, D. M., PROCTER, A. W., Mann, D. M. A., Snowden, J. S., Esiri, M. M., Neary, D., & Francis, P. T. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0992-8 · Cited by 77
Neuroglial Roots of Neurodegenerative Diseases?
Rodriguez, J. J., & Verkhratsky, A. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8157-x · Cited by 77
Self-citationHaider, S., Khaliq, S., Ahmed, S., & Haleem, D. J. (2006) · Amino Acids · doi:10.1007/s00726-005-0310-x · Cited by 77
5‐HT4 receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice
Cachard-Chastel, M., Lezoualc’h, F., Dewachter, I., Deloménie, C., Croes, S., Devijver, H., Langlois, M., LEUVEN, F. V., Sicsic, S., & Gardier, A. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707178 · Cited by 77
Marner, L., Frøkjær, V. G., Kalbitzer, J., Lehel, S., Madsen, K., Baaré, W. F. C., Knudsen, G. M., & Hasselbalch, S. G. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.023 · Cited by 76
Pharmacological consequences of cholinergic plus serotonergic manipulations
Riekkinen, P., Sirviö, J., Valjakka, A., Miettinen, R., & Riekkinen, P. (1991) · Brain Research · doi:10.1016/0006-8993(91)90654-e · Cited by 76
Cunha, U. G. D. V., Rocha, F. L., de Melo, R. Á., Valle, E. A., Neto, J. J. D. S., Brega, R. M., Scoralick, F. M., Silva, S. A., de Oliveira, F. M., Júnior, A. L. D. C., et al. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000102570 · Cited by 76
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease
Aboukhatwa, M. A., Dosanjh, L. E., & Luo, Y. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-10 · Cited by 76
Luellen, B. A., Bianco, L. E., Schneider, L., & Andrews, A. M. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00279.x · Cited by 75
Rosier, A., Dupont, P. J., Peuskens, J., Bormans, G. M., Vandenberghe, R. R., Maes, M. H. J., de Groot, T., Schiepers, C. W., Verbruggen, A., & Mortelmans, L. (1996) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(96)02806-5 · Cited by 75
Millan, M. J., Gobert, A., Roux, S., Porsolt, R. D., Meneses, A., Carli, M., Cara, B. D., Jaffard, R., Rivet, J., Lestage, P. J., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069625 · Cited by 74
Role of 5-HT4 Receptors in the Mouse Passive Avoidance Test
Galeotti, N., Ghelardini, C., & Bartolini, A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37700-6 · Cited by 74
Kia, H. K., Brisorgueil, M., Daval, G., Langlois, X., Hamon, M., & Vergé, D. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00087-5 · Cited by 73
Haider, S., Khaliq, S., & Haleem, D. J. (2007) · PubMed · Cited by 73
Wong, E. H. F., Reynolds, G. P., Bonhaus, D. W., Hsu, S., & Eglen, R. M. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00106-4 · Cited by 72
Serotonergic Regulation of Acetylcholine Release in Rat Frontal Cortex
Hirano, H., Day, J. C., & Fibiger, H. C. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031139.x · Cited by 72
Pérez-García, G., González‐Espinosa, C., & Meneses, A. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.12.013 · Cited by 72
Ontogeny of 5-HT1A receptor expression in the developing hippocampus
Patel, T. D., & Zhou, F. (2005) · Developmental Brain Research · doi:10.1016/j.devbrainres.2005.03.006 · Cited by 70
Meneses, A., Perez-Garcia, G., Liy-Salmerón, G., Flores-Galvez, D., Castillo, C., & Castillo, E. F. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.023 · Cited by 70
Presynaptic Receptors for Dopamine, Histamine, and Serotonin
Feuerstein, T. J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_10 · Cited by 69
Truchot, L., Costes, N., Zimmer, L., Laurent, B., Bars, D. L., Thomas-Antérion, C., Mercier, B., Hermier, M., Vighetto, A., & Krolak‐Salmon, P. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.01.030 · Cited by 69
Eriksson, T. M., Golkar, A., Ekstrom, J. C., Svenningsson, P., & Ögren, S. O. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.026 · Cited by 68
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration
Garibotto, V., Borroni, B., Agosti, C., Premi, E., Alberici, A., Eickhoff, S. B., Brambati, S. M., Bellelli, G., Gasparotti, R., Perani, D., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.004 · Cited by 68
Siddique, H., Hynan, L. S., & Weiner, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04828 · Cited by 68
The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys
Arnsten, A. F. T., Lin, C. H., van Dyck, C. H., & Stanhope, K. J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00162-5 · Cited by 67
Harder, J. A., & Ridley, R. M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00179-3 · Cited by 67
Serotonin‐containing terminals synapse on septohippocampal neurons in the rat
Milner, T. A., & Veznedaroglu, E. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490360304 · Cited by 66
Ramírez, M. J., Cenarruzabeitia, E., Lasheras, B., & del Rı́o, J. A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01471-3 · Cited by 66
Restivo, L., Roman, F. S., Dumuis, A., Bockaert, J., Marchetti, E., & Ammassari‐Teule, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301644 · Cited by 66
Thomas, A. J., Hendriksen, M., Piggott, M. A., Ferrier, I. N., Perry, E. K., Ince, P. G., & O'Brien, J. T. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00728.x · Cited by 63
Elevated Density of [3H]Imipramine Binding in Aged Human Brain
Severson, J. A., Marcusson, J. O., Osterburg, H. H., Finch, C. E., & Winblad, B. G. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07203.x · Cited by 63
Mück‐Šeler, D., Presečki, P., Mimica, N., Mustapić, M., Pivac, N., Perhoč, A. B., Erjavec, G. N., & Folnegović-Šmalc, V. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.004 · Cited by 62
Carli, M., Bonalumi, P., & SAMANIN, R. (1997) · Brain Research · doi:10.1016/s0006-8993(97)81700-3 · Cited by 61
Harder, J. A., Maclean, C. J., Alder, J. T., Francis, P. T., & Ridley, R. M. (1996) · PubMed · Cited by 61
Lelong‐Boulouard, V., Lhonneur, L., Dauphin, F., & Boulouard, M. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0743-2 · Cited by 61
Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset
Carey, G. J., Costall, B., Domeney, A. M., Gerrard, P. A., Jones, D. N. C., Naylor, R. J., & Tyers, M. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90449-p · Cited by 61
Is Antidepressant Treatment Associated with Reduced Cognitive Decline in Alzheimer’s Disease?
Mossello, E., Boncinelli, M., Caleri, V., Cavallini, M. C., Palermo, E., Di Bari, M., Tilli, S., Sarcone, E., Simoni, D., Biagini, C. A., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000121334 · Cited by 61
Orsetti, M., Dellarole, A., Ferri, S., & Ghi, P. (2003) · Learning & Memory · doi:10.1101/lm.67303 · Cited by 61
5-HT1A receptor-mediated inhibition of long-term potentiation in rat visual cortex
Edagawa, Y., Saito, H., & Abe, K. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00286-6 · Cited by 61
Iyo, M., & Yamasaki, T. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90075-4 · Cited by 61
Serotinin, Aging and Cognitive Functions of the Hippocampus
Richter‐Levin, G., & Segal, M. (1996) · Reviews in the Neurosciences · doi:10.1515/revneuro.1996.7.2.103 · Cited by 61
Serotonin/dopamine interaction in learning
Olvera‐Cortés, M. E., Anguiano-Rodríguez, P. B., López‐Vázquez, M. A., & Alfaro, J. S. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00927-8 · Cited by 60
Serotonin 5-HT6 Receptor Antagonists for the Treatment of Alzheimers Disease
Geldenhuys, W. J., & der Schyf, C. V. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785161420 · Cited by 60
Imeri, L., Simoni, M. G. D., Giglio, R., Clavenna, A., & Mancia, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90042-6 · Cited by 60
Mizoguchi, K., Tanaka, Y., & Tabira, T. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.09.048 · Cited by 60
Birthelmer, A., Stemmelin, J., Jackisch, R., & Cassel, J. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00042-x · Cited by 60
Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study
Llopis, S. D. S., Miguélez, M., Peña‐Casanova, J., Poudevida, S., Farré, M., Pacifici, R., Böhm, P., Abanades, S., Verdejo‐García, A., Langohr, K., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107081545 · Cited by 60
Payton, S. M., Cahill, C. M., Randall, J., Gullans, S. R., & Rogers, J. T. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:267 · Cited by 60
Carli, M., Bonalumi, P., & SAMANIN, R. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00034.x · Cited by 59
Adrenergic and serotonergic receptors in aged monkey neocortex
Bigham, M. H., & Lidow, M. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80012-g · Cited by 59
Meneses, A., & Hong, E. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00002-x · Cited by 58
Genes and susceptible loci of Alzheimer’s disease
Shastry, B. S., & Giblin, F. J. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00156-7 · Cited by 58
Molecular imaging of the 5-HT1A receptor in relation to human cognition
Borg, J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.011 · Cited by 58
Rocca, P., Calvarese, P., Faggiano, F., Marchiaro, L., Mathis, F., Rivoira, E., Taricco, B., & Bogetto, F. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0313 · Cited by 58
Marchetti, E., Chaillan, F. A., Dumuis, A., Bockaert, J., Soumireu-Mourat, B., & Roman, F. S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.033 · Cited by 58
Rozzini, L., Chilovi, B. V., Conti, M. Z., Bertoletti, E., Zanetti, M., Trabucchi, M., & Padovani, A. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209990184 · Cited by 57
Evidence for decreased transport of tryptophan hydroxylase in Alzheimer's disease
Burke, W. J., Park, D. H., Chung, H. D., Marshall, G. L., Haring, J. H., & Joh, T. H. (1990) · Brain Research · doi:10.1016/0006-8993(90)90342-9 · Cited by 57
Meneses, A. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1021800822997 · Cited by 57
Age-related changes on monoamine turnover in hippocampus of rats
Venero, J. L., Roza, C. D. L., Machado, A. M., & Cano, J. (1993) · Brain Research · doi:10.1016/0006-8993(93)91191-t · Cited by 56
Laporte, A., Doyen, C., Nevo, I., Chauveau, J., Hauw, J., & Hamon, M. (1996) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(96)00130-5 · Cited by 56
Evidence for retrograde degeneration of epinephrine neurons in Alzheimer's disease
Burke, W. J., Chung, H. D., Huang, J. S., Huang, S. S., Haring, J. H., Strong, R., Marchshall, G. L., & Joh, T. H. (1988) · Annals of Neurology · doi:10.1002/ana.410240409 · Cited by 55
Lüttgen, M., Ögren, S. O., & Meister, B. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.09.001 · Cited by 55
Harkany, T., Dijkstra, I. M., Oosterink, B. J., Horvath, K. M., Ábrahám, I. M., Keijser, J. N., van der Zee, E. A., & Luiten, P. G. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00296-7 · Cited by 55
Evers, E. A. T., van der Veen, F. M., Fekkes, D., & Jolles, J. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707782794032 · Cited by 55
Aberrant morphology of serotonergic fibers in the forebrain of the aged rat
van Luijtelaar, M. G. P. A., Steinbusch, H. W. M., & Tonnaer, J. A. D. M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90638-6 · Cited by 54
List of Drugs in Development for Neurodegenerative Diseases
Fischer, F., Matthisson, M., & Herrling, P. L. (2004) · Neurodegenerative Diseases · doi:10.1159/000077879 · Cited by 54
Schiapparelli, L., Simón, A. M., del Río, J. A., & Frechilla, D. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.02.005 · Cited by 53
Alhaider, A. A., Ageel, A. M., & Ginawi, O. T. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90040-a · Cited by 53
Arjona, A. A., Pooler, A. M., Lee, R. K., & Wurtman, R. J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03153-0 · Cited by 52 · cited 2×
“the 5-HT2A/2C agonist dexnorfenfluramine (DEXNOR) was found to increase APPS in the CSF and to reduce Ab secretion in primary basal forebrain neuronal culture of guinea pig (Arjona et al., 2002).”
Lai, M. K. P., Tsang, S. W. Y., Esiri, M. M., Francis, P. T., Wong, P. T. ‐., & Chen, C. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1936-2 · Cited by 52
Texture of the Nervous System of Man and the Vertebrates
y Cajal, S. R. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6315-3 · Cited by 52
Shapiro, L. A., Bialowas‐McGoey, L. A., & Whitaker‐Azmitia, P. M. (2010) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2010/153657 · Cited by 51
Abe, Y., Aoyagi, A., Hara, T., Abe, K., Yamazaki, R., Kumagae, Y., Naruto, S., Koyama, K., Marumoto, S., Tago, K., et al. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.93.95 · Cited by 51
Schiapparelli, L., Río, J. D., & Frechilla, D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03193.x · Cited by 50
Regulation of serotonin receptor function in the nervous system by lipid rafts and adaptor proteins
Björk, K., Sjögren, B., & Svenningsson, P. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.034 · Cited by 50
Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning
Meneses, A., & Hong, E. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)02266-8 · Cited by 50
Merens, W., Booij, L., Haffmans, P. J., & van der Does, A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107081531 · Cited by 49
Rada, P. V., Mark, G. P., & Hoebel, B. G. (1993) · Brain Research · doi:10.1016/0006-8993(93)91600-w · Cited by 49
Serotonin concentrations in normal aging human brains: Relation to serotonin receptors
Wester, P. O., Hardy, J., Marcusson, J. O., Nyberg, P., & Winblad, B. G. (1984) · Neurobiology of Aging · doi:10.1016/0197-4580(84)90063-0 · Cited by 49
Benninghoff, J., Gritti, A., Rizzi, M., Lamorte, G., Schloesser, R. J., Schmitt, A. G., Robel, S., Genius, J., Moessner, R., Riederer, P. F., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.181 · Cited by 49
Dryden, S. D., Frankish, H. M., Wang, Q., & Williams, G. (1996) · Brain Research · doi:10.1016/0006-8993(96)00329-0 · Cited by 49
A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease
Tsang, S. W. Y., Keene, J., Hope, T., Spence, I., Francis, P. T., Wong, P. T. ‐., Chen, C., & Lai, M. K. P. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.066 · Cited by 49
Frazer, M. E., Hughes, J. E., Mastrangelo, M. A., Tibbens, J. L., Federoff, H. J., & Bowers, W. J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.39 · Cited by 49
Promoter polymorphism of the 5-HT transporter and Alzheimer's disease
Hu, M., Retz, W., Baader, M., Pesold, B., Adler, G., Henn, F. A., Rösler, M., & Thome, J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01544-5 · Cited by 48
β‐amyloid cortical deposits are accompanied by the loss of serotonergic neurons in the dog
Bernedo, V., Insua, D., Suarez, M. L., Santamarina, G., Sarasa, M., & Pesini, P. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.21985 · Cited by 48
Zhou, F. C., Azmitia, E. C., & Bledsoe, S. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(94)00158-v · Cited by 48
Micale, V., Leggio, G. M., Mazzola, C., & Drago, F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.108 · Cited by 48
Combined 192 IgG-saporin and 5,7-dihydroxytryptamine lesions in the male rat brain
Lehmann, O., Jeltsch‐David, H., Lazarus, C., Tritschler, L., Bertrand, F., & Cassel, J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00752-9 · Cited by 47
Zhang, L., Guadarrama, L., Corona-Morales, A. A., Vega‐González, A., Rocha, L., & Escobar, A. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00004 · Cited by 47
Rodriguez, J. J., Noristani, H. N., Hoover, W. B., Linley, S. B., & Vertes, R. P. (2011) · Synapse · doi:10.1002/syn.20920 · Cited by 46
Self-citationMorse, L. J., Payton, S. M., Cuny, G. D., & Rogers, J. T. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:129 · Cited by 46
van Luijtelaar, M. G. P. A., Steinbusch, H. W. M., & Tonnaer, J. A. D. M. (1989) · Experimental Brain Research · doi:10.1007/bf00230689 · Cited by 46
Meneses, A., Manuel‐Apolinar, L., Castillo, C., & Castillo, E. F. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.11.048 · Cited by 46
Effects of 5-HT3 Receptor Antagonism on Hippocampal Cellular Activity in the Freely Moving Rat
Reznic, J., & Staubli, U. V. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.1.517 · Cited by 46
Alves, S. E., Hoskin, E., Lee, S. J., Brake, W. G., Ferguson, D., Luine, V., Allen, P. B., Greengard, P., & McEwen, B. S. (2002) · Synapse · doi:10.1002/syn.10093 · Cited by 45 · cited 2×
“reduces the density of synapses and spines in the hippocampus (Alves et al., 2002; Brezun and Daszuta, 2000a; Mazer et al., 1997).”
Behan, M., & Brownfield, M. S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00337-7 · Cited by 45
Sambeth, A., Riedel, W. J., Tillie, D. E., Blokland, A., Postma, A., & Schmitt, J. A. J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089577 · Cited by 45
Ebinger, G., Bruyland, M., Martin, J. J., Herregodts, P., Cras, P. P., Michotte, Y. M., & Gommé, L. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90128-6 · Cited by 45
Harkany, T., O'Mahony, S., Keijser, J. N., Kelly, J. P., Kónya, C., Borostyánköi, Z., Görcs, T. J., Zarándi, M., Penke, B., Leonard, B. E., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0398 · Cited by 45
Romano, A. G., Quinn, J. L., Li, L., Dave, K. D., Schindler, E. A. D., Aloyo, V. J., & Harvey, J. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2004-7 · Cited by 45
Noristani, H. N., Olabarria, M., Verkhratsky, A., & Rodriguez, J. J. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07274.x · Cited by 45
Self-citationKoenig, J., Cosquer, B., & Cassel, J. (2007) · Hippocampus · doi:10.1002/hipo.20368 · Cited by 44
García-Alloza, M., Zaldua, N., Diez-Ariza, M., Marcos, B., Lasheras, B., Gil-Bea, F. J., & Ramírez, M. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240469.20167.89 · Cited by 44
Harvey, J. A., Quinn, J. L., Liu, R., Aloyo, V. J., & Romano, A. G. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1687-4 · Cited by 44
Relationship of brain tryptophan and serotonin in improving cognitive performance in rats.
Khaliq, S., Haider, S., Ahmed, S., Perveen, T., & Haleem, D. J. (2006) · PubMed · Cited by 44
Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer’s dementia
Gottfries, C. G. (1990) · Springer eBooks · doi:10.1007/978-3-7091-3345-3_4 · Cited by 43
Peddie, C. J., Davies, H. A., Colyer, F. M., Stewart, M. G., & Rodríguez, J. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.003 · Cited by 43
Self-citationMunro, C. A., Brandt, J., Leoutsakos, J., Steele, C. D., Samus, Q. M., Steinberg, M., Rabins, P. V., & Lyketsos, C. G. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200409000-00007 · Cited by 43
Jeltsch‐David, H., Koenig, J., & Cassel, J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.037 · Cited by 43
Imipramine and citalopram facilitate amyloid precursor protein secretion in vitro
PAKASKI, M., BJELIK, A., HUGYECZ, M., KASA, P., JANKA, Z., & KALMAN, J. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.03.004 · Cited by 43
Calcium influx‐independent depression of transmitter release by 5‐HT at lamprey spinal cord synapses
Takahashi, M., Freed, R., Blackmer, T., & Alford, S. T. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0323f.x · Cited by 43
Holm, P. C., Ettrup, A., Klein, A. B., Santini, M. A., Hervig, M. E.-S., Elvang, A. B., Stensbøl, T. B., Mikkelsen, J. D., Knudsen, G. M., & Aznar, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100117 · Cited by 42
Toda, N., Kaneko, T., & Kogen, H. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.273 · Cited by 42
Age-dependent effects of serotonin-1A receptor gene deletion in spatial learning abilities in mice
Wolff, M., Costet, P., Gross, C. T., Hen, R., Ségu, L., & Buhot, M.-C. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.07.012 · Cited by 42
Gasser, U. E., & Dravid, A. R. (1987) · Experimental Neurology · doi:10.1016/0014-4886(87)90053-7 · Cited by 42
Egashira, N., Yano, A., Ishigami, N., Mishima, K., Iwasaki, K., Fujioka, M., Matsushita, M., Nishimura, R., & Fujiwara, M. (2006) · Brain Research · doi:10.1016/j.brainres.2005.10.103 · Cited by 42
Elliott, M. S. J., Ballard, C. G., Kalaria, R. N., Perry, R., Hortobágyi, T., & Francis, P. T. (2009) · Brain · doi:10.1093/brain/awp069 · Cited by 42
Santhosh, L., Estok, K. M., Vogel, R. S., Tamagnan, G. D., Baldwin, R. M., Mitsis, E. M., MacAvoy, M. G., Staley, J. K., & van Dyck, C. H. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.03.007 · Cited by 41
Dementia and Stroke: The Present and Future Epidemic
Cumming, T. B., & Brodtmann, A. G. (2010) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00527.x · Cited by 40
Toda, N., Tago, K., Marumoto, S., Takami, K., Ori, M., Yamada, N., Koyama, K., Naruto, S., Abe, K., Yamazaki, R., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00091-9 · Cited by 40
Hirst, W. D., Andree, T. H., Aschmies, S., Childers, W. E., Comery, T. A., Dawson, L. A., Day, M., Feingold, I. B., Grauer, S. M., Harrison, B. L., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133082 · Cited by 40
Cited by
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Rajmohan, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160612 · Cited by 688
Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M., & Petersen, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063644 · Cited by 438
“with subsequent loss of associated neurons [42].”
Background
Metadata
- Authors
- Rodríguez, J. J., Noristani, H. N., & Verkhratsky, A.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 99
- Issue
- 1
- Pages
- 15-41
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2029821777
- Cited by
- 264
- References
- 469
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.